Apparently, resveratrol has potential uses other than increasing human longevity. Davies Agyekum, a second-year Ph.D. student in the MCG School of Graduate Studies, has found a potential new use for the compound in the treatment of sickle-cell anemia, where resveratrol induces production of fetal hemoglobin and decreases the sickling of red blood cells.
The more observant among you may be thinking, “Hey, if resveratrol increases the amount of hemoglobin, the protein in RBC’s that carries oxygen, shouldn’t it act as a performance enhancer in endurance exercise?” The answer to that seems to be yes but as far as I could find it doesn’t seem to be related to production of hemoglobin but rather production of new mitochondria, as shown in a 2006 study of mice. Whatever the mechanism, resveratrol is looking more and more promising.